Literature DB >> 2850068

Facilitation of noradrenaline release from sympathetic nerves through activation of ACTH receptors, beta-adrenoceptors and angiotensin II receptors.

M Costa1, H Majewski.   

Abstract

1. In rabbit pulmonary artery and left atrial strips previously incubated with [3H]-noradrenaline, the active fragment of adrenocorticotropic hormone (ACTH 1-24, 0.1 microM) significantly enhanced the stimulation-induced (S-I) outflow of radioactivity when a cocktail containing corticosterone (40 microM), cocaine (30 microM) and propranolol (4 microM) was present, but not in the absence of these drugs. In rabbit pulmonary artery a facilitatory effect of ACTH 1-24 (0.1 microM) was also observed when only cocaine (30 microM) was present. 2. ACTH 1-24 (0.1 microM) did not affect the S-I outflow of radioactivity from rat atria, rat pulmonary artery or guinea-pig pulmonary artery, either in the presence or in the absence of the cocktail containing corticosterone (40 microM), cocaine (30 microM) and propranolol (4 microM). These results suggest that the presence of facilitatory prejunctional ACTH receptors may be restricted to rabbit sympathetic nerve endings. 3. Angiotensin II (0.01 microM), but not isoprenaline (0.1 microM) or ACTH 1-24 (0.1 microM), significantly enhanced the S-I outflow of radioactivity from rabbit pulmonary artery. In the presence of phentolamine (1 microM) to block inhibitory alpha 2-adrenoceptors, the facilitatory effect of angiotensin II (0.01 microM) was significantly enhanced, and a significant facilitatory effect of isoprenaline (0.1 microM) and of ACTH 1-24 (0.1 microM) was then revealed. These results suggest that feedback inhibition of noradrenaline release, mediated through the prejunctional alpha 2-adrenoceptor mechanism, buffers increases in noradrenaline release during activation of facilitatory prejunctional receptors. 4. In rabbit pulmonary artery, two concentrations of 8-Br-cyclic AMP, (270 or 540 microM), enhanced the S-I outflow of radioactivity in the presence of phentolamine (1 microM) to a similar extent. In the presence of 8-Br-cyclic AMP (270 microM) and phentolamine, the facilitatory effects of isoprenaline (0.1 microM) and of ACTH,24 (0.1 microM) were blocked, whereas that of angiotensin II (0.01 microM) was not changed. These results suggest that both prejunctional beta-adrenoceptors and ACTH receptors enhance noradrenaline release by generating cyclic AMP. The mechanism by which angiotensin II facilitates noradrenaline release is probably independent of the cyclic AMP second messenger pathway.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850068      PMCID: PMC1854244          DOI: 10.1111/j.1476-5381.1988.tb11730.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

Review 1.  Regulation of noradrenaline release by presynaptic receptor systems.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1977       Impact factor: 5.545

2.  Adenosine 3',5'-monophosphate as the intracellular mediator of the action of adrenocorticotropic hormone on the adrenal cortex.

Authors:  D G Grahame-Smith; R W Butcher; R L Ney; E W Sutherland
Journal:  J Biol Chem       Date:  1967-12-10       Impact factor: 5.157

3.  Effect of isoprenaline on noradrenaline release from sympathetic neurones in rabbit isolated pulmonary artery.

Authors:  O A Nedergaard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

4.  Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.

Authors:  L Cubeddu; E Barnes; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1975-04       Impact factor: 4.030

Review 5.  Local regulation of adrenergic neurotransmission.

Authors:  T C Westfall
Journal:  Physiol Rev       Date:  1977-10       Impact factor: 37.312

Review 6.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

7.  Interactions of angiotensin, phenoxybenzamine and propranolol on noradrenaline release during sympathetic nerve stimulation.

Authors:  K Starke; H J Schümann
Journal:  Eur J Pharmacol       Date:  1972-04       Impact factor: 4.432

8.  Selective metabolic pathways for noradrena-line in the peripheral and in the central nervous system.

Authors:  S Z Langer
Journal:  Med Biol       Date:  1974-12

9.  Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria.

Authors:  H Johnston; H Majewski; I F Musgrave
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

10.  Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery.

Authors:  T Endo; K Starke; A Bangerter; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-02       Impact factor: 3.000

View more
  12 in total

1.  Enhancement of noradrenaline release by angiotensin II and bradykinin in mouse atria: evidence for cross-talk between G(q/11) protein- and G(i/o) protein-coupled receptors.

Authors:  S L Cox; V Schelb; A U Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Dual agonist occupancy of AT1-R-α2C-AR heterodimers results in atypical Gs-PKA signaling.

Authors:  Morgane Bellot; Ségolène Galandrin; Cédric Boularan; Heinrich J Matthies; Fabien Despas; Colette Denis; Jonathan Javitch; Serge Mazères; Samra Joke Sanni; Véronique Pons; Marie-Hélène Seguelas; Jakob L Hansen; Atul Pathak; Aurelio Galli; Jean-Michel Sénard; Céline Galés
Journal:  Nat Chem Biol       Date:  2015-02-23       Impact factor: 15.040

3.  Release inhibitory receptors activation favours the A2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery.

Authors:  Paula Fresco; Carmen Diniz; Glória Queiroz; Jorge Gonçalves
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

4.  Crosstalk between presynaptic angiotensin receptors, bradykinin receptors and alpha 2-autoreceptors in sympathetic neurons: a study in alpha 2-adrenoceptor-deficient mice.

Authors:  Anne-Ulrike Trendelenburg; Angelika Meyer; Werner Klebroff; Serafim Guimarães; Klaus Starke
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  Evidence that M1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C.

Authors:  M Costa; M Barrington; H Majewski
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

6.  Effect of phorbol ester and pertussis toxin on the enhancement of noradrenaline release by angiotensin II in mouse atria.

Authors:  I F Musgrave; H Majewski
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

7.  Activation of beta 2-adrenoceptors by isoprenaline and adrenaline enhances noradrenaline release in cortical kidney slices of young spontaneously hypertensive rats.

Authors:  L C Rump; M J Schuster; P Schollmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

Review 8.  Integrative Physiological Aspects of Brain RAS in Hypertension.

Authors:  Sharon D B de Morais; Julia Shanks; Irving H Zucker
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

9.  Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein.

Authors:  S Foucart; H Majewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

10.  Effects of cyclic AMP and analogues on neurogenic transmission in the rat tail artery.

Authors:  S Ouedraogo; J C Stoclet; B Bucher
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.